-
1
-
-
40649091062
-
Vaccines for leishmaniasis in the fore coming 25years
-
Palatnik-de-Sousa CB. Vaccines for leishmaniasis in the fore coming 25years. Vaccine 2008; 26: 1709-1724.
-
(2008)
Vaccine
, vol.26
, pp. 1709-1724
-
-
Palatnik-de-Sousa, C.B.1
-
2
-
-
0030249268
-
Leishmaniasis. Public health aspects and control
-
Desjeux P. Leishmaniasis. Public health aspects and control. Clin Dermatol 1996; 14: 417-423.
-
(1996)
Clin Dermatol
, vol.14
, pp. 417-423
-
-
Desjeux, P.1
-
3
-
-
0023131284
-
Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis
-
Convit J, Castellanos PL, Rondon A, et al. Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis. Lancet 1987; 1: 401-405.
-
(1987)
Lancet
, vol.1
, pp. 401-405
-
-
Convit, J.1
Castellanos, P.L.2
Rondon, A.3
-
4
-
-
0022359726
-
Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate)
-
Chulay JD, Spencer HC & Mugambi M. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate). Am J Trop Med Hyg 1985; 34: 702-709.
-
(1985)
Am J Trop Med Hyg
, vol.34
, pp. 702-709
-
-
Chulay, J.D.1
Spencer, H.C.2
Mugambi, M.3
-
5
-
-
0035067363
-
Leishmaniasis: current status of vaccine development
-
Handman E. Leishmaniasis: current status of vaccine development. Clin Microbiol Rev 2001; 14: 229-243.
-
(2001)
Clin Microbiol Rev
, vol.14
, pp. 229-243
-
-
Handman, E.1
-
6
-
-
0030939757
-
Leishmania vaccines: old and new
-
Handman E. Leishmania vaccines: old and new. Parasitol Today 1997; 13: 236-238.
-
(1997)
Parasitol Today
, vol.13
, pp. 236-238
-
-
Handman, E.1
-
7
-
-
0037073536
-
The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis
-
Alimohammadian MH, Khamesipour A, Darabi H, et al. The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis. Vaccine 2002; 21: 174-180.
-
(2002)
Vaccine
, vol.21
, pp. 174-180
-
-
Alimohammadian, M.H.1
Khamesipour, A.2
Darabi, H.3
-
8
-
-
0029620397
-
Vaccines against leishmaniasis
-
Modabber F. Vaccines against leishmaniasis. Ann Trop Med Parasitol 1995; 89(Suppl 1): 83-88.
-
(1995)
Ann Trop Med Parasitol
, vol.89
, Issue.SUPPL. 1
, pp. 83-88
-
-
Modabber, F.1
-
9
-
-
0030248707
-
Comparative safety and immunogenicity trial of two killed Leishmania major vaccines with or without BCG in human volunteers
-
Bahar K, Dowlati Y, Shidani B, et al. Comparative safety and immunogenicity trial of two killed Leishmania major vaccines with or without BCG in human volunteers. Clin Dermatol 1996; 14: 489-495.
-
(1996)
Clin Dermatol
, vol.14
, pp. 489-495
-
-
Bahar, K.1
Dowlati, Y.2
Shidani, B.3
-
10
-
-
0029330303
-
Meetings on vaccine studies towards the control of leishmaniasis. UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR) February 13-22 and April 4-5, 1995
-
Grimaldi Junior G. Meetings on vaccine studies towards the control of leishmaniasis. UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR) February 13-22 and April 4-5, 1995. Mem Inst Oswaldo Cruz 1995; 90: 553-556.
-
(1995)
Mem Inst Oswaldo Cruz
, vol.90
, pp. 553-556
-
-
Grimaldi Junior, G.1
-
11
-
-
0023219965
-
Mycobacterium bovis BCG-induced protection against cutaneous and systemic Leishmania major infections of mice
-
Fortier AH, Mock BA, Meltzer MS & Nacy CA. Mycobacterium bovis BCG-induced protection against cutaneous and systemic Leishmania major infections of mice. Infect Immun 1987; 55: 1707-1714.
-
(1987)
Infect Immun
, vol.55
, pp. 1707-1714
-
-
Fortier, A.H.1
Mock, B.A.2
Meltzer, M.S.3
Nacy, C.A.4
-
12
-
-
0024348540
-
Cell-mediated immunity in localized cutaneous leishmaniasis patients before and after treatment with immunotherapy or chemotherapy
-
Castes M, Moros Z, Martinez A, et al. Cell-mediated immunity in localized cutaneous leishmaniasis patients before and after treatment with immunotherapy or chemotherapy. Parasite Immunol 1989; 11: 211-222.
-
(1989)
Parasite Immunol
, vol.11
, pp. 211-222
-
-
Castes, M.1
Moros, Z.2
Martinez, A.3
-
13
-
-
0028925755
-
Mycobacterium and Leishmania: stowaways in the endosomal network
-
Russell DG. Mycobacterium and Leishmania: stowaways in the endosomal network. Trends Cell Biol 1995; 5: 125-128.
-
(1995)
Trends Cell Biol
, vol.5
, pp. 125-128
-
-
Russell, D.G.1
-
14
-
-
0030249321
-
Stepwise safety trial of a killed Leishmania vaccine in Iran
-
Dowlati Y, Ehsasi S, Shidani B & Bahar K. Stepwise safety trial of a killed Leishmania vaccine in Iran. Clin Dermatol 1996; 14: 497-502.
-
(1996)
Clin Dermatol
, vol.14
, pp. 497-502
-
-
Dowlati, Y.1
Ehsasi, S.2
Shidani, B.3
Bahar, K.4
-
15
-
-
0033524709
-
A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran
-
Momeni AZ, Jalayer T, Emamjomeh M, et al. A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran. Vaccine 1999; 17: 466-472.
-
(1999)
Vaccine
, vol.17
, pp. 466-472
-
-
Momeni, A.Z.1
Jalayer, T.2
Emamjomeh, M.3
-
16
-
-
0034346696
-
Safety and immunogenicity of an autoclaved Leishmania major vaccine
-
Khalil EA, Elhassan AM, Zijlstra EE, et al. Safety and immunogenicity of an autoclaved Leishmania major vaccine. East Afr Med J 2000; 77: 468-470.
-
(2000)
East Afr Med J
, vol.77
, pp. 468-470
-
-
Khalil, E.A.1
Elhassan, A.M.2
Zijlstra, E.E.3
-
17
-
-
0028153628
-
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
-
Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271: 698-702.
-
(1994)
JAMA
, vol.271
, pp. 698-702
-
-
Colditz, G.A.1
Brewer, T.F.2
Berkey, C.S.3
-
18
-
-
0034455173
-
Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature
-
Brewer TF. Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin Infect Dis 2000; 31(Suppl 3): S64-S67.
-
(2000)
Clin Infect Dis
, vol.31
, Issue.SUPPL. 3
-
-
Brewer, T.F.1
-
19
-
-
0028872014
-
Variation in protection by BCG: implications of and for heterologous immunity
-
Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346: 1339-1345.
-
(1995)
Lancet
, vol.346
, pp. 1339-1345
-
-
Fine, P.E.1
-
20
-
-
0031899819
-
Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization
-
Gallichan WS & Rosenthal KL. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization. J Infect Dis 1998; 177: 1155-1161.
-
(1998)
J Infect Dis
, vol.177
, pp. 1155-1161
-
-
Gallichan, W.S.1
Rosenthal, K.L.2
-
21
-
-
0036375003
-
Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses
-
Xin KQ, Ooki T, Mizukami H, et al. Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses. Hum Gene Ther 2002; 13: 1571-1581.
-
(2002)
Hum Gene Ther
, vol.13
, pp. 1571-1581
-
-
Xin, K.Q.1
Ooki, T.2
Mizukami, H.3
-
22
-
-
0034782438
-
Intranasal BCG vaccination protects BALB/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs
-
Lyadova IV, Vordermeier HM, Eruslanov EB, Khaidukov SV, Apt AS & Hewinson RG. Intranasal BCG vaccination protects BALB/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs. Clin Exp Immunol 2001; 126: 274-279.
-
(2001)
Clin Exp Immunol
, vol.126
, pp. 274-279
-
-
Lyadova, I.V.1
Vordermeier, H.M.2
Eruslanov, E.B.3
Khaidukov, S.V.4
Apt, A.S.5
Hewinson, R.G.6
-
23
-
-
0034256992
-
Intranasal vaccination of mice against infection with Mycobacterium tuberculosis
-
Falero-Diaz G, Challacombe S, Banerjee D, Douce G, Boyd A & Ivanyi J. Intranasal vaccination of mice against infection with Mycobacterium tuberculosis. Vaccine 2000; 18: 3223-3229.
-
(2000)
Vaccine
, vol.18
, pp. 3223-3229
-
-
Falero-Diaz, G.1
Challacombe, S.2
Banerjee, D.3
Douce, G.4
Boyd, A.5
Ivanyi, J.6
-
24
-
-
0033801613
-
Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routes
-
Abolhassani M, Lagranderie M, Chavarot P, Balazuc AM & Marchal G. Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routes. Infect Immun 2000; 68: 5657-5662.
-
(2000)
Infect Immun
, vol.68
, pp. 5657-5662
-
-
Abolhassani, M.1
Lagranderie, M.2
Chavarot, P.3
Balazuc, A.M.4
Marchal, G.5
-
25
-
-
33745185757
-
Leishmaniasis vaccine candidates for development: a global overview
-
Khamesipour A, Rafati S, Davoudi N, Maboudi F & Modabber F. Leishmaniasis vaccine candidates for development: a global overview. Indian J Med Res 2006; 123: 423-438.
-
(2006)
Indian J Med Res
, vol.123
, pp. 423-438
-
-
Khamesipour, A.1
Rafati, S.2
Davoudi, N.3
Maboudi, F.4
Modabber, F.5
-
26
-
-
0030969398
-
Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae
-
Abou-Zeid C, Gares MP, Inwald J, et al. Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect Immun 1997; 65: 1856-1862.
-
(1997)
Infect Immun
, vol.65
, pp. 1856-1862
-
-
Abou-Zeid, C.1
Gares, M.P.2
Inwald, J.3
-
27
-
-
0030026839
-
Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains
-
Lagranderie MR, Balazuc AM, Deriaud E, Leclerc CD & Gheorghiu M. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun 1996; 64: 1-9.
-
(1996)
Infect Immun
, vol.64
, pp. 1-9
-
-
Lagranderie, M.R.1
Balazuc, A.M.2
Deriaud, E.3
Leclerc, C.D.4
Gheorghiu, M.5
-
28
-
-
0022234330
-
A limiting dilution assay for quantifying Leishmania major in tissues of infected mice
-
Titus RG, Marchand M, Boon T & Louis JA. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 1985; 7: 545-555.
-
(1985)
Parasite Immunol
, vol.7
, pp. 545-555
-
-
Titus, R.G.1
Marchand, M.2
Boon, T.3
Louis, J.A.4
-
29
-
-
32844459122
-
Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis
-
Rafati S, Zahedifard F & Nazgouee F. Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis. Vaccine 2006; 24: 2169-2175.
-
(2006)
Vaccine
, vol.24
, pp. 2169-2175
-
-
Rafati, S.1
Zahedifard, F.2
Nazgouee, F.3
-
30
-
-
0242690076
-
Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG
-
Mahmoodi M, Khamesipour A, Dowlati Y, et al. Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG. Clin Exp Immunol 2003; 134: 303-308.
-
(2003)
Clin Exp Immunol
, vol.134
, pp. 303-308
-
-
Mahmoodi, M.1
Khamesipour, A.2
Dowlati, Y.3
-
31
-
-
7144254432
-
Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran
-
Sharifi I, FeKri AR, Aflatonian MR, et al. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet 1998; 351: 1540-1543.
-
(1998)
Lancet
, vol.351
, pp. 1540-1543
-
-
Sharifi, I.1
FeKri, A.R.2
Aflatonian, M.R.3
-
32
-
-
0035424854
-
Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways
-
Jankovic D, Liu Z & Gause WC. Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol 2001; 22: 450-457.
-
(2001)
Trends Immunol
, vol.22
, pp. 450-457
-
-
Jankovic, D.1
Liu, Z.2
Gause, W.C.3
-
33
-
-
0035989325
-
Manipulation of immune responses to Mycobacterium bovis by vaccination with IL-2- and IL-18-secreting recombinant bacillus Calmette Guerin
-
Young S, O'Donnell M, Lockhart E, et al. Manipulation of immune responses to Mycobacterium bovis by vaccination with IL-2- and IL-18-secreting recombinant bacillus Calmette Guerin. Immunol Cell Biol 2002; 80: 209-215.
-
(2002)
Immunol Cell Biol
, vol.80
, pp. 209-215
-
-
Young, S.1
O'Donnell, M.2
Lockhart, E.3
-
34
-
-
0025300228
-
Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine
-
Liew FY, Millott S, Parkinson C, Palmer RM & Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol 1990; 144: 4794-4797.
-
(1990)
J Immunol
, vol.144
, pp. 4794-4797
-
-
Liew, F.Y.1
Millott, S.2
Parkinson, C.3
Palmer, R.M.4
Moncada, S.5
-
35
-
-
0031684625
-
Induction of nitric oxide in human monocytes and monocyte cell lines by Mycobacterium tuberculosis
-
Jagannath C, Actor JK & Hunter RL Jr. Induction of nitric oxide in human monocytes and monocyte cell lines by Mycobacterium tuberculosis. Nitric Oxide 1998; 2: 174-186.
-
(1998)
Nitric Oxide
, vol.2
, pp. 174-186
-
-
Jagannath, C.1
Actor, J.K.2
Hunter Jr., R.L.3
-
36
-
-
0027281549
-
Leishmania major infection in BALB/c mice: protection or exacerbation by treatment with different doses of BCG
-
Stefani MM, Muller I & Louis J. Leishmania major infection in BALB/c mice: protection or exacerbation by treatment with different doses of BCG. Res Immunol 1993; 144: 233-243.
-
(1993)
Res Immunol
, vol.144
, pp. 233-243
-
-
Stefani, M.M.1
Muller, I.2
Louis, J.3
-
37
-
-
29144437001
-
Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: anatomical sites of bacterial replication and immune activity
-
Aldwell FE, Baird MA, Fitzpatrick CE, et al. Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: anatomical sites of bacterial replication and immune activity. Immunol Cell Biol 2005; 83: 549-553.
-
(2005)
Immunol Cell Biol
, vol.83
, pp. 549-553
-
-
Aldwell, F.E.1
Baird, M.A.2
Fitzpatrick, C.E.3
-
38
-
-
33749357217
-
Similar functional activity of dendritic cells recruited to the mesenteric lymph nodes of newborn and adult mice after the rectal delivery of Mycobacterium bovis BCG
-
Abolhassani M, Lagranderie M, Caminshi I, et al. Similar functional activity of dendritic cells recruited to the mesenteric lymph nodes of newborn and adult mice after the rectal delivery of Mycobacterium bovis BCG. Microbes Infect 2006; 8: 2341-2351.
-
(2006)
Microbes Infect
, vol.8
, pp. 2341-2351
-
-
Abolhassani, M.1
Lagranderie, M.2
Caminshi, I.3
|